Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 2:28 AM
Ignite Modification Date:
2025-12-26 @ 1:02 AM
NCT ID:
NCT02584634
Group ID:
EG001
Title:
Group B: Avelumab + Lorlatinib
Description:
Participants with locally advanced or metastatic ALK-positive NSCLC received avelumab 10 mg/kg as a 1-hour IV infusion once every 2 weeks (Day 1 of each cycle) and lorlatinib 100 mg (starting dose) orally once a day (QD) on a continuous daily dosing schedule.
Deaths Number Affected:
15
Deaths Number At Risk:
None
Serious Number Affected:
21
Serious Number At Risk:
31
Other Number Affected:
28
Other Number At Risk:
31
Study:
NCT02584634
Results Section:
NCT02584634
Adverse Events Module:
NCT02584634